50548

CPT 50548 - Laparoscopy, Surgical; Nephrectomy with Total Ureterectomy

---

Short Descriptor

Laparoscopic nephrectomy with total ureterectomy

---

Full Descriptor

Laparoscopy, surgical; nephrectomy with total ureterectomy

This code describes the complete laparoscopic (or robotic-assisted laparoscopic) removal of the entire kidney and the entire ipsilateral ureter from the ureteropelvic junction (UPJ) down to and including the distal ureter at the bladder. No separate CPT code exists for robotic-assisted performance — CPT 50548 applies to both pure laparoscopic and robotic-assisted (da Vinci) approaches. This is the minimally invasive equivalent of open nephroureterectomy (CPT 50234 / 50236).

---

Code Tree / Hierarchy

Surgery (10000-69999)  
└── Urinary System (50010-53899)  
└── Kidney (50010-50593)  
└── Laparoscopic Procedures on the Kidney (50541-50549)  
├── 50541 - Laparoscopy, surgical; ablation of renal cysts  
├── 50542 - Laparoscopy, surgical; ablation of renal mass lesion(s)  
├── 50543 - Laparoscopy, surgical; partial nephrectomy  
├── 50544 - Laparoscopy, surgical; pyeloplasty  
├── 50545 - Laparoscopy, surgical; radical nephrectomy (with Gerota's fascia, adrenal, renal vein/artery)  
├── 50546 - Laparoscopy, surgical; nephrectomy, including PARTIAL ureterectomy  
├── 50547 - Laparoscopy, surgical; donor nephrectomy, living donor (cold preservation)  
├── 50548 - Laparoscopy, surgical; nephrectomy with TOTAL ureterectomy ✅ ← THIS CODE  
└── 50549 - Unlisted laparoscopy procedure, kidney

    Open Nephroureterectomy Counterparts (for comparison):
        ├── 50220 - Nephrectomy, including partial ureterectomy; any open approach
        ├── 50225 - Nephrectomy; complicated by prior surgery on same kidney
        ├── 50230 - Nephrectomy; radical, open
        ├── 50234 - Nephrectomy with total ureterectomy and bladder cuff; through same incision (OPEN)
        └── 50236 - Nephrectomy with total ureterectomy and bladder cuff; through separate incision (OPEN)

---

Clinical Overview

CPT 50548 describes a laparoscopic or robotic-assisted laparoscopic nephroureterectomy (LNU/RNU) — the removal of the entire kidney and the entire ipsilateral ureter. This is the gold standard surgical treatment for high-risk upper tract urothelial carcinoma (UTUC), which includes malignancies of the renal pelvis (C65.x) and ureter (C66.x). It may also be performed for severely damaged, non-functioning kidneys with concomitant ureteral disease.

The procedure is designated as Inpatient Only (IPO) under CMS OPPS policy, meaning it cannot be reimbursed in an outpatient hospital or ASC setting under Medicare. An inpatient admission is required.

Primary Clinical Indications

• High-risk upper tract urothelial carcinoma (UTUC) — malignancy of the renal pelvis or ureter — most common indication
• Low-risk UTUC — when nephron-sparing/endoscopic management has failed or is not appropriate
• Renal pelvic or ureteral transitional cell carcinoma with hydronephrosis or ureteral obstruction
• Non-functioning kidney with concomitant ureteral pathology (chronic obstruction, stone disease, recurrent infections)
• Xanthogranulomatous pyelonephritis with diffuse ureteral involvement
• End-stage renal disease of a single kidney with ureteral malignancy when the contralateral kidney is adequate
• Congenital ureteral anomalies in select pediatric cases (rare; typically managed with reconstruction first)

Surgical Technique Overview (Standard LNU/RNU)

1. General anesthesia is administered; patient is positioned in modified flank or lateral decubitus position
2. A pneumoperitoneum is established and laparoscopic or robotic ports are placed (typically 3-5 ports)
3. The colon is mobilized medially (Gerota’s fascia is entered)
4. The renal hilum is identified and the renal artery and vein are controlled, clipped, and divided
5. The kidney is mobilized within or outside Gerota’s fascia depending on the oncologic indication
6. The ureter is identified, mobilized distally, and followed into the pelvis to the level of the bladder
7. The distal ureter and bladder cuff are managed via one of three approaches:
   • Endoscopic (cystoscopic) approach: Using a Collins knife or laser, the intramural ureter is circumferentially incised cystoscopically and pushed/plucked into the retroperitoneum; this is the “pluck technique”
   • Open (extravesical) approach: A small incision (Pfannenstiel or Gibson) is made to directly excise the distal ureter and bladder cuff under direct vision, which is then sutured closed
   • Laparoscopic/robotic intracorporeal approach: The distal ureter and bladder cuff are excised entirely laparoscopically or robotically without a second incision
8. The specimen (kidney + entire ureter ± bladder cuff) is placed in a specimen retrieval bag and extracted through an extended port site or a separate Pfannenstiel incision
9. The bladder is irrigated and a urethral catheter is placed
10. Ports are removed, fascia closed at extraction site, skin closed

💡 Coding Note on the Distal Ureter/Bladder Cuff: The management of the distal ureter and bladder cuff is one of the most nuanced coding scenarios for CPT 50548. See the Coding Examples and Tips & Pitfalls sections for detailed guidance on when 52214 and/or 50650 may or may not be separately reportable.

---

Includes - Bundled Services

The following services are integral to and included in CPT 50548 and must NOT be separately reported during the same operative session:

Bundled Service	CPT Code(s)	Notes
Laparoscopic port placement and pneumoperitoneum	—	Integral to any laparoscopic procedure
Cystourethroscopy (diagnostic)	52000	When performed solely for orientation/inspection during the same session
Ureteral catheterization (intraoperative stent for identification)	52005	Placement of a ureteral catheter intraoperatively to help identify the ureter during laparoscopic dissection is integral
Retroperitoneal dissection, ureterolysis	50715	Mobilization of the ureter required to complete the total ureterectomy is integral
Intraoperative ureteral stent placement as part of the nephroureterectomy	52332	If a stent is placed simply as part of the procedure completion, it is bundled
Adrenal gland removal if incidental and not a distinct radical component	60540	Note: If adrenalectomy is performed as a distinct, medically indicated procedure (e.g., adrenal mass, adrenal invasion), it MAY be separately reportable — verify NCCI and document distinctness clearly
Hemostasis and drain placement	—	Routine wound management always included
Specimen retrieval and bagging	—	Always included

---

Related & Excluded CPT Codes

CPT	Description	Relationship to 50548
50546	Laparoscopy, surgical; nephrectomy including partial ureterectomy	Critical distinction - Use 50546 when only PART of the ureter is removed (e.g., upper ureter only). Use 50548 only when the ENTIRE ureter is removed. This is the #1 coding error for this procedure family.
50545	Laparoscopy, surgical; radical nephrectomy (Gerota’s fascia, adrenal, renal vein/artery)	Use when kidney removed radically with Gerota’s fascia without total ureterectomy; cannot be reported with 50548 — mutually exclusive
50234	Nephrectomy with total ureterectomy and bladder cuff; through same incision (OPEN)	Open approach equivalent — distinct from 50548 (laparoscopic)
50236	Nephrectomy with total ureterectomy and bladder cuff; through separate incision (OPEN)	Open approach with separate incision for distal ureter — distinct from 50548
50543	Laparoscopy, surgical; partial nephrectomy	Kidney-sparing; no ureterectomy involved
50547	Laparoscopy, surgical; donor nephrectomy (living donor)	Living donor kidney harvest — no ureterectomy; entirely different clinical context
52214	Cystourethroscopy with fulguration of trigone, bladder neck, urethra, periurethral glands	May be separately reportable when used to endoscopically excise/fulgurate the ureteral orifice and intramural ureter (bladder cuff) as a distinct cystoscopic component of the nephroureterectomy — see Coding Tips section
50650	Ureterectomy with bladder cuff (separate procedure)	May be separately reportable when distal ureter and bladder cuff are excised via a SEPARATE open approach/incision (Pfannenstiel) — requires NCCI override modifier (-59, -XS, or -XU)
52355	Cystourethroscopy with ureteroscopy and/or pyeloscopy; with resection of ureteral or renal pelvic tumor	May be performed prior to nephroureterectomy for staging/confirmation — may be separately reportable at a DIFFERENT session or with appropriate modifier if distinct
38770	Bilateral pelvic lymphadenectomy	Regional lymph node dissection may be separately reportable when performed as a distinct surgical component — verify NCCI PTP edits
38571	Laparoscopic bilateral total pelvic lymphadenectomy	Laparoscopic lymphadenectomy, if performed as a staged or concurrent oncologic step — verify NCCI
49000	Exploratory laparotomy	Not separately reportable when open extraction of specimen is simply part of the laparoscopic approach
50549	Unlisted laparoscopy procedure, kidney	Use if the laparoscopic procedure performed does not match any existing CPT descriptor (rare edge case)
88305 / 88307	Surgical pathology	Separately billable by pathology for kidney/ureter resection specimens

---

RVU & Reimbursement (2026)

All values reflect national averages before Geographic Practice Cost Index (GPCI) adjustments. Always verify the final 2026 wRVU for CPT 50548 directly from the CMS MPFS Annual ZIP file (available at cms.gov/medicare/payment/fee-schedules/physician). CPT 50548 is subject to the 2026 -2.5% efficiency adjustment applied to non-time-based services.

Physician Fee Schedule (Professional Component)

Metric	Value	Notes
wRVU - 2026 (Estimated, Post-Adjustment)	~20.02	Based on 2025 baseline (~20.52) less CMS 2026 -2.5% efficiency adjustment; verify via CMS MPFS
wRVU - 2025 Baseline	~20.52	Pre-2026 efficiency revaluation
Estimated Facility Physician Payment (National)	~$672	~20.02 × $33.57 CF; before GPCI
CMS 2026 Conversion Factor (Qualifying APM)	$33.57	+3.77% from 2025
CMS 2026 Conversion Factor (Non-Qualifying APM)	$33.40	+3.26% from 2025
Global Period	090 days	Major surgery global package
Multiple Procedure Indicator	2	Subject to multiple procedure reduction (50% on lower-valued procedure)
Bilateral Surgery Indicator	Modifier 50 if applicable	Bilateral nephroureterectomy is extremely rare; typically N/A
Inpatient Only (IPO)	YES	Not payable in HOPD outpatient or ASC settings under Medicare

Note

⚠️ Inpatient Only Designation: CMS designates CPT 50548 as an Inpatient Only procedure under OPPS. If a Medicare patient undergoes this procedure in an outpatient/ambulatory setting, the hospital will NOT receive facility payment under Medicare Part B OPPS. The procedure must be performed with an inpatient admission for facility reimbursement. Always confirm appropriate site of service before scheduling.

Facility / Inpatient Context

Setting	Applicable	Payment Mechanism
Inpatient Hospital	✅ Yes	MS-DRG (IPPS)
Hospital Outpatient (HOPD)	❌ No (IPO under Medicare)	Not applicable / Non-covered OPPS
ASC	❌ No (IPO under Medicare)	Not applicable
Commercial/Non-Medicare HOPD	⚠️ Verify payer	Commercial payers may not follow CMS IPO list

---

Global Period & Post-Op Billing

• Global Period: 090 days (major surgery)
• Decision for surgery E/M (day before or day of): Append modifier -57 to the E/M code when the decision to perform this major surgery is made at that visit
• Pre-operative E/M on day of surgery (routine): Included in global package — do not separately bill
• Post-operative visits (90 days): Included — all routine follow-up related to the procedure is bundled
• Staged or related procedure within global period: Append modifier -58 (e.g., planned ureteral stent removal, planned surveillance cystoscopy considered staged)
• Unplanned return to OR for complication: Append modifier -78 (e.g., return for port-site hernia repair, intraabdominal hemorrhage, urine leak)
• Unrelated procedure during global period: Append modifier -79 to the unrelated CPT code
• Unrelated E/M during global period: Append modifier -24 to the E/M code
• Transfer of post-op care: Modifier -54 (surgical care only) for the operating surgeon; modifier -55 (post-op care) for the receiving provider

---

Assistant at Surgery

Indicator	Value
Assistant at Surgery Payable	Yes - Indicator 1
MD/DO Assistant Modifier	-80 - Assistant Surgeon
MD Assistant (No Qualified Resident)	-82 - Teaching hospital setting
PA-C / NP / CNS as Assistant	-AS - Medicare APP assistant at surgery
Co-Surgery	Not applicable
Team Surgery	Not applicable

Note

Given the complexity of laparoscopic or robotic nephroureterectomy — particularly the hilar dissection, distal ureteral management, and potential for vascular complications — an assistant surgeon is clinically standard and routinely necessary. Medicare reimburses MD/DO assistants at 16% of the primary surgeon’s allowed amount (modifiers -80/-82). APP assistants using modifier -AS are reimbursed at approximately 72% of the physician rate (85% × 85%). Always verify individual commercial payer assistant surgery policies, as many commercial plans require prior authorization or have specific credentialing requirements for assistant surgeons in laparoscopic/robotic cases.

---

HCC Status & Risk Adjustment

HCC status applies to ICD-10-CM diagnosis codes, not CPT codes. Upper tract urothelial carcinoma and associated conditions are among the most HCC-impactful diagnoses associated with this procedure.

ICD-10-CM	Description	HCC Status	HCC Category	Notes
C65.1	Malignant neoplasm of right renal pelvis	✅ HCC-12	Cancer - various	🔑 Most common oncologic indication
C65.2	Malignant neoplasm of left renal pelvis	✅ HCC-12	Cancer - various
C65.9	Malignant neoplasm of renal pelvis, unspecified	✅ HCC-12	Cancer - various	Use only when laterality not documented — query the physician
C66.1	Malignant neoplasm of right ureter	✅ HCC-12	Cancer - various	Ureteral TCC/UUC
C66.2	Malignant neoplasm of left ureter	✅ HCC-12	Cancer - various
C66.9	Malignant neoplasm of ureter, unspecified	✅ HCC-12	Cancer - various	Avoid — laterality should be queryable
C64.1	Malignant neoplasm of right kidney (not renal pelvis)	✅ HCC-12	Cancer - various	Renal cell carcinoma with ureteral extension
C64.2	Malignant neoplasm of left kidney (not renal pelvis)	✅ HCC-12	Cancer - various
C79.01	Secondary malignant neoplasm of right kidney/renal pelvis	✅ HCC-12	Metastatic Cancer	Metastatic involvement
C79.02	Secondary malignant neoplasm of left kidney/renal pelvis	✅ HCC-12	Metastatic Cancer
N18.4	CKD Stage 4	✅ HCC-328	CKD	Common concurrent condition — contralateral kidney function
N18.5	CKD Stage 5	✅ HCC-327	CKD	Pre-dialysis; critical for post-op management
E11.65	Type 2 DM with hyperglycemia	✅ HCC-37	Diabetes	Common comorbidity — always code if managed
I50.9	Heart failure, unspecified	✅ HCC-85	Heart failure	May affect perioperative risk/LOS
N13.1	Hydronephrosis with ureteral stricture	❌ Not HCC	—	Non-neoplasm indication
N20.1	Calculus of ureter	❌ Not HCC	—	Rare non-neoplasm indication
Z85.51	Personal history of malignant neoplasm of bladder	❌ Not HCC	—	Prior bladder cancer — important secondary code for UTUC
Z80.51	Family history of malignant neoplasm of kidney	❌ Not HCC	—	Secondary context code
Z90.5	Acquired absence of kidney	❌ Not HCC	—	Status code post-nephrectomy — use on subsequent encounters

Note

💡 HCC Strategy: When C65.x or C66.x (UTUC) is the principal diagnosis, every correctly documented and managed comorbidity adds to the patient’s RAF score. For Medicare Advantage plans, ensure complete diagnosis capture. Query the physician for CKD staging, diabetes manifestation specificity, and any cardiovascular comorbidities addressed during the perioperative period.

---

MS-DRG Assignment (Inpatient Facility)

Inpatient facility claims use ICD-10-PCS codes (not CPT codes) to drive MS-DRG assignment. The following ICD-10-PCS codes correspond to the laparoscopic nephroureterectomy procedure.

ICD-10-PCS Reference (Laparoscopic/Percutaneous Endoscopic Approach)

The ICD-10-PCS approach value for laparoscopic surgery is 4 = Percutaneous Endoscopic. Two ICD-10-PCS codes are typically required: one for the kidney resection and one for the ureteral resection.

ICD-10-PCS Code	Description
0TT04ZZ	Resection of Right Kidney, Percutaneous Endoscopic Approach
0TT14ZZ	Resection of Left Kidney, Percutaneous Endoscopic Approach
0TT64ZZ	Resection of Right Ureter, Percutaneous Endoscopic Approach
0TT74ZZ	Resection of Left Ureter, Percutaneous Endoscopic Approach

For a right laparoscopic nephroureterectomy: Report both 0TT04ZZ + 0TT64ZZ For a left laparoscopic nephroureterectomy: Report both 0TT14ZZ + 0TT74ZZ If a robotic arm (da Vinci) is used, the approach value remains 4 (Percutaneous Endoscopic); no additional PCS code is assigned for robotic assistance in standard ICD-10-PCS tables. If the distal ureter/bladder cuff is managed via a separate open incision, the open ureterectomy component may use approach value 0 (Open) for the second PCS code (0TT60ZZ or 0TT70ZZ) to accurately reflect the hybrid approach.

MS-DRG Mapping

Clinical Scenario	MS-DRG	CC/MCC Tier	MDC
Laparoscopic nephroureterectomy for UTUC / renal pelvis / ureteral neoplasm	659	With MCC	MDC 11
Laparoscopic nephroureterectomy for UTUC / renal pelvis / ureteral neoplasm	660	With CC	MDC 11
Laparoscopic nephroureterectomy for UTUC / renal pelvis / ureteral neoplasm	661	Without CC/MCC	MDC 11
Laparoscopic nephroureterectomy for non-neoplasm (stricture, stones, non-functioning kidney)	656	With MCC	MDC 11
Laparoscopic nephroureterectomy for non-neoplasm	657	With CC	MDC 11
Laparoscopic nephroureterectomy for non-neoplasm	658	Without CC/MCC	MDC 11

Note

💡 Facility Coding Optimization: The difference between DRG 659 (neoplasm, MCC) and DRG 661 (neoplasm, no CC/MCC) can represent a substantial difference in reimbursement. Ensure all documented and managed comorbidities are captured: CKD (N18.x), DM with specificity (E11.65, E11.649, etc.), hypertensive CKD (I12.x / I13.x), anemia (D63.1), malnutrition if documented, respiratory complications, deep vein thrombosis, and any post-procedural complications.

---

Common Modifiers

Modifier	Description	When to Use with 50548
-22	Increased Procedural Services	Significantly greater complexity than typical — examples include prior ipsilateral renal surgery with extensive adhesions, post-radiation fibrosis making ureteral dissection unusually difficult, massive tumor burden with adherence to major vessels, or markedly prolonged operative time. Requires a detailed cover letter + operative report. Payer review common.
-51	Multiple Procedures	When 50548 is performed on the same day as another separately reportable unrelated surgical procedure; applied to the lower-valued service
-52	Reduced Services	Procedure started but not fully completed (e.g., only partial ureterectomy achieved before conversion) — document clearly
-53	Discontinued Procedure	Procedure abandoned after anesthesia induction due to patient safety concerns — document extensively; claim subject to significantly reduced payment
-54	Surgical Care Only	Use when the operating surgeon will NOT provide post-operative care (formal or informal transfer of care per 2026 CMS policy update) — new requirement effective 2026 for all 90-day globals with expected transfers
-55	Post-Operative Care Only	Used by the receiving provider who takes over post-op care after the 90-day global is initiated
-57	Decision for Surgery	Appended to the E/M code when the decision to perform this major surgery (090 global) is made the day before or day of the procedure
-58	Staged or Related Procedure	Planned return to OR within the global period — triggers a new global period (e.g., planned ureteral stent removal at 4-6 weeks, secondary bladder cuff revision)
-59	Distinct Procedural Service	NCCI override for separately reportable components performed at the same session (e.g., 52214 for endoscopic bladder cuff management, 50650 for open bladder cuff excision) — prefer -XE, -XS, or -XU for Medicare
-78	Unplanned Return to OR	Complication during global period requiring return to OR (e.g., port-site hernia, lymphocele, urine leak, hemorrhage) — does NOT reset global period
-79	Unrelated Procedure During Global	Completely unrelated surgical procedure within the 90-day global period
-80	Assistant Surgeon	MD/DO operating as assistant surgeon
-82	No Qualified Resident Available	Teaching hospital assistant billing
-AS	APP as Assistant at Surgery	PA-C, NP, CNS assistant (Medicare/most Medicaid)
-LT / -RT	Left / Right Laterality	When only the left or right nephroureterectomy is performed (standard unilateral documentation) — some payers require these for claims clarity
-XS	Separate Structure	Preferred Medicare modifier over -59 when reporting 52214 or 50650 as separately reportable (distinct anatomic structure — bladder vs. kidney/ureter)
-XU	Unusual Non-Overlapping Service	Acceptable Medicare alternative to -59 when the procedure uses different technology/approach (e.g., endoscopic bladder cuff vs. laparoscopic nephrectomy)

---

Commonly Paired ICD-10-CM Diagnosis Codes

Always code to the highest level of specificity supported by documentation. Laterality is required for C64.x, C65.x, and C66.x — do not default to “unspecified” without querying the physician.

ICD-10-CM	Description	Notes
C65.1	Malignant neoplasm of right renal pelvis	🔑 Most common indication; HCC-12; confirm laterality
C65.2	Malignant neoplasm of left renal pelvis	🔑 HCC-12
C66.1	Malignant neoplasm of right ureter	HCC-12; ureteral TCC
C66.2	Malignant neoplasm of left ureter	HCC-12
C64.1	Malignant neoplasm of right kidney, not renal pelvis	RCC with ureteral extension — less common indication
C64.2	Malignant neoplasm of left kidney, not renal pelvis
C79.01	Secondary malignant neoplasm of right kidney and renal pelvis	Metastatic disease
C79.02	Secondary malignant neoplasm of left kidney and renal pelvis
Z85.51	Personal history of malignant neoplasm of bladder	UTUC patients frequently have prior or concurrent bladder cancer — always capture when documented
Z85.528	Personal history of other malignant neoplasm of kidney	Prior renal cancer history
N13.1	Hydronephrosis with ureteral stricture, NEC	Non-neoplasm indication — ureteral obstruction causing hydronephrosis
N13.4	Hydroureter	Ureteral dilation from chronic obstruction
N20.1	Calculus of ureter	Stone disease causing irreversible ureteral/renal damage
N20.0	Calculus of kidney	Concurrent renal calculus
N28.82	Megaloureter	Congenital or acquired massive ureteral dilation
N28.89	Other specified disorders of kidney and ureter	Catch-all for non-neoplasm ureteral conditions
Q62.11	Congenital occlusion of ureteropelvic junction	Congenital UPJ obstruction with irreversible damage (pediatric)
N16	Renal tubulo-interstitial disorders in diseases classified elsewhere	Infectious or metabolic causes of renal destruction
N18.4	CKD Stage 4	Contralateral kidney function — critical to document
N18.5	CKD Stage 5	Pre-dialysis — critical comorbidity
E11.65	Type 2 DM with hyperglycemia	Common comorbidity — always code with specificity
I12.9	Hypertensive CKD with Stage 1-4 or unspecified	HCC-qualifying when CKD Stage 4-5 is present
Z90.5	Acquired absence of kidney	Status code for subsequent encounters post-nephroureterectomy
Z79.899	Other long term (current) drug therapy	For patients on checkpoint inhibitors or systemic agents for UTUC

---

Coding Examples / Scenarios

---

Scenario 1 - Standard Laparoscopic Nephroureterectomy for Renal Pelvic Cancer (Oncologic)

Clinical Situation: A 64-year-old male with a 3.2 cm high-grade urothelial carcinoma of the right renal pelvis confirmed on ureteroscopy and CT urogram. He undergoes a right laparoscopic nephroureterectomy. The distal ureter is managed laparoscopically (intracorporeal distal ureteral dissection with bladder cuff excised through a small port-site extension). No separate cystoscopy or open bladder cuff incision is used.

CPT (Professional Claim):

• 50548-RT - Laparoscopy, surgical; nephrectomy with total ureterectomy, right side

ICD-10-CM:

• C65.1 - Malignant neoplasm of right renal pelvis

ICD-10-PCS (Facility Claim):

• 0TT04ZZ - Resection of Right Kidney, Percutaneous Endoscopic Approach
• 0TT64ZZ - Resection of Right Ureter, Percutaneous Endoscopic Approach

Expected MS-DRG: 661 - Kidney and Ureter Procedures for Neoplasm without CC/MCC (if no significant comorbidities are documented and managed)

✅ No additional CPT codes for the distal ureteral management — fully intracorporeal; all components are included in 50548.

---

Scenario 2 - Laparoscopic Nephroureterectomy + Endoscopic Bladder Cuff Excision (52214)

Clinical Situation: A 71-year-old female with left ureteral transitional cell carcinoma (mid-ureter, high-grade). The urologist performs a laparoscopic left nephroureterectomy. Prior to or during the procedure, the surgeon uses cystoscopy with a Collins knife to circumferentially incise the intramural left ureter and surrounding bladder cuff (the “pluck technique”), pushing the distal ureter into the retroperitoneum for laparoscopic retrieval.

CPT (Professional Claim):

• 50548-LT - Laparoscopic nephrectomy with total ureterectomy, left
• 52214-XS (or -59) - Cystourethroscopy with fulguration/excision of trigone area (endoscopic bladder cuff management as a distinct cystoscopic service on a separate anatomic structure)

ICD-10-CM:

• C66.2 - Malignant neoplasm of left ureter

⚠️ Nuanced Coding Alert: Whether 52214 is separately reportable with 50548 has been debated among urology coding experts. The expert consensus from AAPC Urology Coding Alert supports that the endoscopic excision of the ureteral orifice and bladder cuff using cystoscopy is a distinct surgical step performed via a different approach (cystoscopic vs. laparoscopic) on a different anatomic structure (bladder vs. kidney/ureter). Modifier -XS (separate structure) or -XU (unusual non-overlapping service) for Medicare and -59 for non-Medicare payers is appropriate. Always verify current NCCI PTP edits and your MAC’s LCA before billing 52214 with 50548.

---

Scenario 3 - Hybrid Nephroureterectomy: Laparoscopic + Open Distal Ureterectomy (50650)

Clinical Situation: A 68-year-old male undergoes a hand-assisted laparoscopic right nephroureterectomy for a high-grade ureteral tumor. After the laparoscopic component is complete and the upper ureter is divided, the surgeon makes a separate Pfannenstiel incision to directly expose and excise the distal right ureter including a generous bladder cuff under open visualization. The cystotomy is sutured closed directly.

CPT (Professional Claim):

• 50548-RT - Laparoscopic nephrectomy with total ureterectomy
• 50650-XS (or -59) - Ureterectomy with bladder cuff (separate procedure); modifier -XS because performed through a separate open incision on a separate anatomic structure (bladder)

ICD-10-CM:

• C66.1 - Malignant neoplasm of right ureter

💡 The key factor supporting separate reporting of 50650 here is the separate surgical approach (open Pfannenstiel incision) for a distinct structural component (distal ureter + bladder cuff). The operative report must clearly document that the distal ureter/bladder cuff excision was performed through a separate incision. NCCI edits between 50548 and 50650 may require an override modifier.

---

Scenario 4 - Robotic-Assisted Laparoscopic Nephroureterectomy (Da Vinci)

Clinical Situation: A 59-year-old female with left renal pelvis urothelial carcinoma undergoes a robotic-assisted (da Vinci) left radical nephroureterectomy. The robot assists with hilar dissection, ureteral mobilization, distal ureteral and bladder cuff dissection (all intracorporeal). Specimen retrieved through an extended port site.

CPT (Professional Claim):

• 50548-LT - Laparoscopy, surgical; nephrectomy with total ureterectomy

ICD-10-CM:

• C65.2 - Malignant neoplasm of left renal pelvis

✅ There is no separate CPT code for robotic-assisted laparoscopic nephroureterectomy. CPT 50548 applies regardless of whether the laparoscopic approach is pure laparoscopic or robotic-assisted (da Vinci, Versius, Hugo, etc.). The robotic system does not change the CPT code selection. This is confirmed by the AMA, CMS, and the da Vinci 2026 Coding and Reimbursement Guide.

---

Scenario 5 - Nephroureterectomy + Regional Lymph Node Dissection (Template Dissection)

Clinical Situation: A 67-year-old male with high-grade, T3 left renal pelvis urothelial carcinoma. The urologist performs a robotic left nephroureterectomy with a concurrent ipsilateral template retroperitoneal lymph node dissection for oncologic staging.

CPT (Professional Claim):

• 50548-LT - Laparoscopic/robotic nephrectomy with total ureterectomy
• 38570-51 - Laparoscopy, surgical; with retroperitoneal lymph node sampling (biopsy), single or multiple (multiple procedure modifier -51)

ICD-10-CM:

• C65.2 - Malignant neoplasm of left renal pelvis

🔍 Verify NCCI PTP edits between 50548 and 38570 before billing. If a PTP edit exists, a modifier (-59/-XE/-XS) may be needed with supporting documentation of a distinct, separately performed lymph node dissection. Not all commercial payers follow NCCI exactly — check individual payer policies.

---

Scenario 6 - Increased Complexity: Modifier -22 (Prior Ipsilateral Surgery + Radiation)

Clinical Situation: A 74-year-old male with left renal pelvis urothelial carcinoma has a history of prior left partial nephrectomy for RCC 8 years ago and subsequent flank radiation for recurrence. The laparoscopic nephroureterectomy is complicated by dense perirenal fibrosis, obliterated tissue planes, unexpected adherence of the kidney to the spleen and tail of pancreas, total operative time of 7 hours (typical is 2.5-4 hours), and intraoperative consultation with a general surgeon for splenic mobilization.

CPT (Professional Claim):

• 50548-LT-22 - Laparoscopic nephrectomy with total ureterectomy, left, with significantly increased complexity

ICD-10-CM:

• C65.2 - Malignant neoplasm of left renal pelvis
• Z85.528 - Personal history of malignant neoplasm of kidney (prior RCC)
• Z96.641 - Presence of right artificial hip joint (if applicable) — (placeholder: code applicable concurrent history)

📝 A comprehensive cover letter must accompany this claim detailing: (1) the specific factors creating extraordinary difficulty, (2) the prolonged operative time with documentation of typical time, (3) the need for additional specialist consultation, and (4) attachment of the full operative report. Anticipated additional reimbursement: 20-30% above standard allowable if approved.

---

Scenario 7 - Unplanned Return to OR: Port-Site Hernia Repair (Modifier -78)

Clinical Situation: On post-op day 12 following laparoscopic right nephroureterectomy, the patient develops a symptomatic port-site hernia at the specimen extraction site requiring return to the OR for laparoscopic repair.

CPT (Return to OR Claim):

• 49652-78 - Laparoscopy, surgical; repair, ventral, umbilical, spigelian, or epigastric hernia; reducible (or appropriate hernia repair CPT based on findings); modifier -78 indicates unplanned return to OR for related complication within the global period

ICD-10-CM:

• K43.9 - Ventral hernia without obstruction or gangrene (or appropriate hernia code based on findings)
• T81.89XA - Other complications of procedures, NEC, initial encounter

⚠️ Modifier -78 restricts reimbursement to the intraoperative portion only of the new procedure’s global fee. A new 90-day global period does NOT begin with modifier -78. The original 50548 global period continues uninterrupted.

---

Scenario 8 - Inpatient Facility Coding Optimization (DRG with Comorbidities)

Clinical Situation: A 69-year-old male admitted for laparoscopic right nephroureterectomy for right renal pelvis urothelial carcinoma (C65.1). Documented and managed comorbidities during admission: CKD Stage 4 (N18.4), hypertension with CKD stage 4 (I12.9), Type 2 DM with diabetic CKD (E11.65), and mild protein-energy malnutrition documented and addressed by nutrition (E44.1).

ICD-10-CM (Inpatient Sequencing):

• C65.1 - Malignant neoplasm of right renal pelvis (principal diagnosis)
• N18.4 - CKD Stage 4 (CC or MCC — verify current grouper version)
• I12.9 - Hypertensive CKD with Stage 1-4 (CC)
• E11.65 - Type 2 DM with hyperglycemia (CC)
• E44.1 - Mild protein-energy malnutrition (CC)

ICD-10-PCS:

• 0TT04ZZ - Resection of Right Kidney, Percutaneous Endoscopic Approach
• 0TT64ZZ - Resection of Right Ureter, Percutaneous Endoscopic Approach

Expected MS-DRG: 659 - Kidney and Ureter Procedures for Neoplasm with MCC (if CKD Stage 4 or malnutrition qualifies as MCC in current grouper) — or 660 with CC.

💡 The difference between DRG 659 (with MCC) and DRG 661 (no CC/MCC) can represent several thousand dollars in facility reimbursement. Each documented and coded comorbidity matters. Query the attending for: CKD staging (what eGFR was documented?), DM complication specificity (is there DM-related CKD, E11.65?), and whether nutrition was formally assessed and documented by dietitian and co-signed by the attending.

---

Scenario 9 - Surveillance Cystoscopy During Global Period (Modifier Guidance)

Clinical Situation: Four weeks after laparoscopic nephroureterectomy for UTUC, the patient returns for a planned surveillance cystoscopy (AUA UTUC guidelines recommend surveillance cystoscopy at 3 months post-op). This was planned at the time of surgery.

CPT:

• 52000-58 - Cystourethroscopy; modifier -58 indicates this is a staged/related procedure performed during the global period of 50548

⚠️ Some coders argue that surveillance cystoscopy during the global period of a nephroureterectomy is truly unrelated to the surgical procedure itself (it doesn’t treat a complication or perform a staged component of the surgery) and should use modifier -24 (unrelated E/M) or -79 (unrelated procedure). The correct modifier here depends on whether the cystoscopy was specifically planned as a staged follow-up component of the UTUC surgical treatment plan. If it was planned at the time of surgery as part of the oncologic treatment plan, -58 is appropriate. If it was a routine separate surveillance visit, -79 is more appropriate. Document the relationship clearly in the operative/planning notes.

---

Documentation Requirements

For CPT 50548 to be properly supported for billing, medical necessity, and audit defense, the operative report should clearly document:

• Clinical indication: Confirmed diagnosis (histopathology from prior ureteroscopy/biopsy, imaging findings) supporting nephroureterectomy over nephron-sparing alternatives
• Approach: Laparoscopic (pure, hand-assisted, or robotic-assisted) — name the system if robotic (da Vinci, etc.)
• Laterality: Explicitly state right or left
• Total ureterectomy confirmed: The operative note must state that the entire ureter was removed — not just the proximal ureter. This distinguishes 50548 from 50546 (partial ureterectomy)
• Distal ureteral management technique: Clearly describe HOW the distal ureter and bladder cuff were managed (intracorporeal laparoscopic, endoscopic pluck technique with cystoscopy, open separate incision). This drives the decision on whether 52214 or 50650 is separately billable
• Hilar control: Documentation of renal artery and vein ligation
• Gerota’s fascia: Note whether the kidney was removed within or outside Gerota’s fascia (relevant for oncologic completeness documentation)
• Adrenal gland management: Was the adrenal gland removed or preserved? If removed, was it incidental or for a distinct indication?
• Lymph node dissection: If performed, document extent, template, number of nodes
• Specimen disposition: Entire specimen (kidney + entire ureter) sent to pathology — note both components
• Bladder repair: If a cystotomy was made for bladder cuff excision, document closure technique and confirmation of watertight repair
• Port sites and extraction site: Document port placement and extraction incision used for specimen retrieval
• Estimated blood loss
• Postoperative condition, catheter placement, and drain placement
• Complications if any

---

Coding Tips & Pitfalls

💡 50548 vs. 50546 — The #1 Error. The single most important distinction in this code family is whether a partial or total ureterectomy was performed. CPT 50546 = laparoscopic nephrectomy with partial ureterectomy (proximal ureter segment only). CPT 50548 = laparoscopic nephrectomy with the entire ureter removed down to the bladder. The operative note must explicitly state the entire ureter was removed. If the documentation does not specify, query the surgeon before assigning 50548.

💡 Robotic = Still 50548. There is no separate CPT code for robotic-assisted laparoscopic nephroureterectomy. Whether the procedure is performed with straight laparoscopic instruments or with the da Vinci robotic system, CPT 50548 is the correct code. Do not use an unlisted code (50549) for robotic cases — this is a common miscoding error.

💡 Inpatient Only — No ASC or HOPD under Medicare. This is one of the most significant billing errors for 50548. If this is performed on a Medicare patient in a non-inpatient setting, the facility will not receive OPPS reimbursement. The procedure requires an inpatient admission. Commercial payers do not necessarily follow CMS’s Inpatient Only list, so verify payer-specific policies for non-Medicare patients.

💡 52214 and 50650 — Separately Reportable or Not? This is one of the most nuanced coding scenarios in urology. The general rule: if the bladder cuff is managed endoscopically (cystoscopically), separately billing 52214 is supported per AAPC expert guidance with a NCCI override modifier (-XS or -59). If the distal ureter is managed via a separate open incision, 50650 may be separately billable with modifier -XS or -59. If the entire procedure including the distal ureter is handled laparoscopically/intracorporeally, no additional code is separately billable — it is all part of 50548. Always review the operative report closely to determine the technique used.

💡 Modifier -54 in 2026 — New Requirement. CMS finalized a new 2026 policy requiring surgeons who do not intend to provide post-operative care (whether through formal or informal transfer) to append modifier -54 to 90-day global surgical codes. This is a significant change from prior policy. If the urologist performs 50548 but refers the patient back to their primary care physician or a different urologist for post-op management, modifier -54 is now required by CMS. The receiving provider appends -55 to their E/M claims for the post-op visits.

💡 Laterality is required. Always append -LT or -RT to CPT 50548 when billing. This is especially critical for bilateral payers, MACs with laterality edits, and for any concurrent or future ipsilateral procedures within the global period.

💡 Z90.5 on subsequent encounters. After nephroureterectomy, code Z90.5 (Acquired absence of kidney) on all subsequent encounters for this patient. This is important for clinical context, clinical decision support, and potential future procedures (e.g., ureteroscopy of the solitary kidney requires special consideration).

💡 Prior bladder cancer history matters. UTUC and bladder urothelial carcinoma are strongly related. UTUC patients have a high incidence of concurrent or prior bladder cancer. Always code Z85.51 (Personal history of malignant neoplasm of bladder) when documented in the medical record and relevant to the current encounter. This supports ongoing surveillance cystoscopy billing and risk stratification documentation.